Event
Bioengineering Seminar Series: Chris Gemmiti
Friday, April 13, 2012
11:00 a.m.-12:00 p.m.
Room 1200 Jeong H. Kim Engineering Bldg.
Professor Silvia Muro
muro@umd.edu
Commercialization of Live Cell Products: Failures and Successes
Chris Gemmiti
Director, Oral Regeneration
Organogenesis Inc.
Organogenesis is a leader in the field of regenerative medicine, with its two allogeneic cell-based FDA-approved products: Apligraf®, for diabetic foot ulcers and venous leg ulcers, and Gintuit for mucogingival conditions. The company was founded in 1985 and received its first approval in 1998 as a public company. Since that time, the company has seen significant change across many areas: the R&D innovation pipeline, supply chain, restructuring to a private company, health insurance reimbursement landscape, manufacturing, and commercialization. This presentation will give an overview of the company and the establishment of the flagship product, Apligraf. The focus will take the audience through how the company has evolved and what key lessons were learned, both in good times and in bad. It will conclude with a brief word about the newly approved product, Gintuit, and some prospects for the future.
About the Speaker
Dr. Chris Gemmiti, PhD is the Director for the Oral Regeneration business unit at Organogenesis Inc (Canton, MA), a leader in the field of tissue engineering and regenerative medicine. He is responsible for cross-functional, strategic alignment for the launch of a new living cell-based product for the dental surgery market, as well as building a product pipeline for this new business unit. This product, Gintuit, was recently approved by the FDA as a combination biologic-device.
Concurrently, Chris is the Head of the Industry Committee for the journal Tissue Engineering. This newly formed committee is charged with increasing industrial relevance for the journal and plans to publish articles and reviews directly from industry executives and experts. Chris holds PhD in Biomedical Engineering jointly conferred by the Georgia Institute of Technologys College of Engineering and Emory Universitys School of Medicine. A minor in Management and Certificate of Engineering Entrepreneurship was also granted by Georgia Techs College of Management.
